VIST vs BMA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

VIST

32.6
AI Score
VS
BMA Wins

BMA

61.7
AI Score

Investment Advisor Scores

VIST

33score
Recommendation
AVOID NEW MONEY

BMA

62score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric VIST BMA Winner
Forward P/E 6.2735 3.0979 BMA
PEG Ratio 0 0.4681 Tie
Revenue Growth 102.3% 1.2% VIST
Earnings Growth 29.8% 3.5% VIST
Tradestie Score 32.6/100 61.7/100 BMA
Profit Margin 23.6% 9.0% VIST
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY STRONG BUY BMA

Relative Price Performance (Last 90 Days)

VIST 1M: +9.6% · 3M: +12.4% BMA 1M: -7.0% · 3M: -28.4%

Current Technical Phase

VIST

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.0% over 20 days), RSI 64

RSI (14): 64.0 · Price: $74.84

BMA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.3 · Price: $66.04

Fundamentals Snapshot

Metric VIST BMA
Market Cap — —
Forward P/E 0.4 0.0
Trailing P/E 9.4 12.9
Revenue (TTM) — —
Revenue Growth 1.0% 0.0%
Gross Margin 0.8% 1.0%
Operating Margin 0.4% 0.3%
EPS 7.48 4.89
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BMA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.